Shareholder Votes

BTCS Inc. shareholders approved To ratify the appointment of Forvis Mazars, LLP as the Company’s independent registered public accounting firm for fiscal year 2026 at the 2026-06-08 meeting.

“To ratify the appointment of Forvis Mazars, LLP as the Company’s independent registered public accounting firm for fiscal year 2026. 31,395,000 180,816 — 376,359 0”

BTCS Inc. shareholders approved To elect the following directors: Charles Allen, Charles Lee, Ashley DeSimone at the 2026-06-08 meeting.

“To elect the following directors: Charles Allen 18,417,918 — 263,814 — 13,270,443 Charles Lee 18,002,240 — 679,492 — 13,270,443 Ashley DeSimone 17,661,803 — 1,019,929 — 13,270,443”

PMGC Holdings Inc. shareholders approved Approve potential adjournment of Annual Meeting to solicit additional proxies at the 2026-06-05 meeting.

“Proposal 4 : Shareholders considered a proposal to approve the potential adjournment of the Annual Meeting to solicit additional proxies if required. The proposal was approved.* FOR* AGAINST ABSTAIN 6,527,449 13,200 24,185”

PMGC Holdings Inc. shareholders approved Ratify appointment of HTL International, LLC as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-05 meeting.

“Proposal 3 : Shareholders were asked to ratify the appointment of HTL International, LLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The proposal was approved. FOR AGAINST ABSTAIN 6,536,284 4,827 23,723”

PMGC Holdings Inc. shareholders approved Approve amendment to Bylaws to provide for a staggered Board of two classes at the 2026-06-05 meeting.

“Proposal No. 2 : to approve an amendment to the Company’s Bylaws to provide for a staggered Board comprised of two classes of directors, designated Class I and Class II, with Class I Directors serving for three (3) year terms and Class II Directors serving for one (1) year terms. FOR AGAINST ABSTAIN 6,525,599 15,443 23,792”

PMGC Holdings Inc. shareholders approved Election of five directors at the 2026-06-05 meeting.

“Proposal 1 : Five (5) directors were nominated for election to serve until the next annual meeting and until their successors are duly elected and qualified. Each nominee was elected. The voting results for each director were: Braeden Lichti FOR AGAINST ABSTAIN 6,526,627 14,410 23,797”

Astera Labs, Inc. shareholders approved Advisory vote on frequency of future say-on-pay votes at the 2026-06-04 meeting.

“Proposal No. 4 Every One Year Two Years Three Years Abstain Broker Non-Votes Say-on-Frequency 113,239,044 36,793 1,872,912 61,348 26,229,468”

Astera Labs, Inc. shareholders approved Advisory vote on compensation of named executive officers at the 2026-06-04 meeting.

“Proposal No. 3 For Against Abstain Broker Non-Votes Say-on-Pay 111,520,205 3,615,962 73,930 26,229,468”

Astera Labs, Inc. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-06-04 meeting.

“Proposal No. 2 For Against Abstain Broker Non-Votes* Auditor Ratification 141,298,992 115,708 24,865 -”

Astera Labs, Inc. shareholders approved Election of Class II Director Nominees at the 2026-06-04 meeting.

“Proposal No. 1 Election of Class II Director Nominees For Withheld Broker Non-Votes Sanjay Gajendra 98,435,707 16,774,390 26,229,468 Craig Barratt 96,549,639 18,660,458 26,229,468 Michael Hurlston 78,685,214 36,524,883 26,229,468”

AtaiBeckley Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-04 meeting.

“Proposal 2 - Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. The results were as follows: For Against Abstain Broker Non-votes 201,864,060 1,182,226 862,275 0”

AtaiBeckley Inc. shareholders approved Election of Sabrina Martucci Johnson, Amir Kalali, M.D. and Andrea Heslin Smiley as Class I directors to hold office until the Company’s annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified at the 2026-06-04 meeting.

“Proposal 1 - Election of Sabrina Martucci Johnson, Amir Kalali, M.D. and Andrea Heslin Smiley as Class I directors to hold office until the Company’s annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified. The results were as follows: Nominee For Withheld Broker Non-votes Sabrina Martucci Johnson 146,111,468 581,411 57,215,682 Amir Kalali, M.D. 142,900,102 3,792,777 57,215,682 Andrea Heslin Smiley 145,186,528 1,506,351 57,215,682”

GARMIN LTD shareholders approved Approve maximum aggregate compensation for Garmin’s Board of Directors for period between 2026 annual general meeting and 2027 annual general meeting at the 2026-06-05 meeting.

“14. The shareholders approved a binding vote to approve the maximum aggregate compensation for Garmin’s Board of Directors for the period between the 2026 annual general meeting and the 2027 annual general meeting.”

GARMIN LTD shareholders approved Approve Fiscal Year 2027 maximum aggregate compensation for Garmin’s Executive Management at the 2026-06-05 meeting.

“13. The shareholders approved a binding vote to approve the Fiscal Year 2027 maximum aggregate compensation for Garmin’s Executive Management.”

GARMIN LTD shareholders approved Resolution approving Garmin’s Swiss Non-Financial Matters Report for fiscal year ended December 27, 2025 at the 2026-06-05 meeting.

“12. The shareholders passed a resolution approving Garmin’s Swiss Non-Financial Matters Report for the fiscal year ended December 27, 2025.”

GARMIN LTD shareholders approved Advisory resolution approving Garmin’s Swiss Statutory Compensation Report for fiscal year ended December 27, 2025 at the 2026-06-05 meeting.

“11. The shareholders passed an advisory resolution approving Garmin’s Swiss Statutory Compensation Report for the fiscal year ended December 27, 2025.”

GARMIN LTD shareholders approved Advisory resolution approving compensation of Named Executive Officers at the 2026-06-05 meeting.

“10. The shareholders passed an advisory resolution approving the compensation of Garmin’s Named Executive Officers.”

GARMIN LTD shareholders approved Ratify appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for fiscal year ending December 26, 2026 and re-elect Ernst & Young Ltd as statutory auditor for another one-year term at the 2026-06-05 meeting.

“9. The shareholders ratified the appointment of Ernst & Young LLP as Garmin’s Independent Registered Public Accounting Firm for the fiscal year ending December 26, 2026 and re-election of Ernst & Young Ltd as Garmin’s statutory auditor for another one-year term.”

GARMIN LTD shareholders approved Re-elect Wuersch & Gering LLP as independent voting rights representative for a term extending until completion of the 2027 annual general meeting at the 2026-06-05 meeting.

“8. The shareholders re-elected the law firm of Wuersch & Gering LLP as independent voting rights representative for a term extending until completion of the 2027 annual general meeting.”

GARMIN LTD shareholders approved Re-elect four members of the Compensation Committee each for a term extending until completion of the 2027 annual general meeting at the 2026-06-05 meeting.

“7. The shareholders re-elected four members of the Compensation Committee, each for a term extending until completion of the 2027 annual general meeting.”

GARMIN LTD shareholders approved Re-elect Min H. Kao as Executive Chairman of the Board of Directors for a term extending until completion of the 2027 annual general meeting at the 2026-06-05 meeting.

“6. The shareholders re-elected Min H. Kao as Executive Chairman of the Board of Directors for a term extending until completion of the 2027 annual general meeting.”

GARMIN LTD shareholders approved Re-election of six directors each for a term extending until completion of the 2027 annual general meeting at the 2026-06-05 meeting.

“5. The shareholders re-elected six directors, each for a term extending until completion of the 2027 annual general meeting.”

GARMIN LTD shareholders approved Discharge members of the Board of Directors and Executive Management from liability for fiscal year ended December 27, 2025 at the 2026-06-05 meeting.

“The tabulation of votes on this matter was as follows: For Against Abstain Non-votes 99,005,980 1,081,147 22,377,268 27,279,587 5. The shareholders re-elected six directors, each for a term extending until completion of the 2027 annual general meeting.”

GARMIN LTD shareholders approved Approve payment of a cash dividend in the aggregate amount of U.S. $4.20 per outstanding share out of Garmin’s reserve from capital contribution in four equal installments at the 2026-06-05 meeting.

“3. The shareholders approved the payment of a cash dividend in the aggregate amount of U.S. $4.20 per outstanding share out of Garmin’s reserve from capital contribution in four equal installments.”

GARMIN LTD shareholders approved Approve appropriation of available earnings at the 2026-06-05 meeting.

“2. The shareholders approved the appropriation of available earnings.”

GARMIN LTD shareholders approved Approve 2025 Annual Report and consolidated and statutory financial statements at the 2026-06-05 meeting.

“1. The shareholders approved Garmin’s 2025 Annual Report, including the consolidated financial statements of Garmin for the fiscal year ended December 27, 2025 and the statutory financial statements of Garmin for the fiscal year ended December 27, 2025.”

ARKO Corp. shareholders approved Ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year at the 2026-06-04 meeting.

“Proposal 3: Ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year: Votes Votes Broker For Against Abstentions Non-Votes 95,991,876 718,988 2,658 —”

ARKO Corp. shareholders approved Approval of a non-binding advisory resolution approving the compensation of the Company’s named executive officers as disclosed in the Company’s 2026 Proxy Statement for the Annual Meeting at the 2026-06-04 meeting.

“Proposal 2: Approval of a non-binding advisory resolution approving the compensation of the Company’s named executive officers as disclosed in the Company’s 2026 Proxy Statement for the Annual Meeting: Votes Votes Broker For Against Abstentions Non-Votes 74,199,282 5,966,842 660,455 15,886,943”

ARKO Corp. shareholders approved Election of six directors to the Board to hold office until the Company's 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified at the 2026-06-04 meeting.

“Proposal 1: Election of six directors to the Board to hold office until the Company’s 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified: Votes Votes Broker Director For Withheld Non-Votes Sherman K. Edmiston III 72,713,274 8,113,305 15,886,943 Yona Fogel 80,691,831 134,748 15,886,943 Avram Friedman 79,218,543 1,608,036 15,886,943 Andrew R. Heyer 60,801,588 20,024,991 15,886,943 Laura Shapira Karet 79,835,177 991,402 15,886,943 Arie Kotler 80,458,273 368,306 15,886,943”

MARKETWISE, INC. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-04 meeting.

“The stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, by the following votes: Votes For Votes Against Votes Abstained 14,415,900 2,416 246,035”

MARKETWISE, INC. shareholders approved Say-on-Frequency Proposal at the 2026-06-04 meeting.

“The stockholders approved, on an advisory (non-binding) basis, one year as the interval for future Say-on-Pay votes , by the following votes: One Year Two Years Three Years Abstain Broker Non-Votes 7,615,818 99,163 5,879,057 29,690 1,040,623”

MARKETWISE, INC. shareholders rejected Say-on-Pay Proposal at the 2026-06-04 meeting.

“The stockholders did not approve, on an advisory (non-binding) basis, the compensation of our named executive officers , by the following votes: Votes For Votes Against Votes Abstained Broker Non-Votes 6,117,351 7,476,751 29,626 1,040,623”

MARKETWISE, INC. shareholders approved Election of Directors at the 2026-06-04 meeting.

“The stockholders elected Matthew Turner to serve as a Class II director until the 2029 Annual Meeting of Stockholders, by the following votes: Nominee Votes For Votes Withheld Broker Non-Votes Matthew Turner 13,366,939 256,789 1,040,623”

CASELLA WASTE SYSTEMS INC shareholders approved Ratification of RSM US LLP as independent auditors at the 2026-06-04 meeting.

“Proposal 3: The appointment of RSM US LLP, an independent registered public accounting firm, as the Company’s independent auditors for the fiscal year ending December 31, 2026 was ratified. Votes For Votes Against Votes Abstaining 67,536,781 2,672,490 19,798”

CASELLA WASTE SYSTEMS INC shareholders approved Advisory vote on executive compensation at the 2026-06-04 meeting.

“Proposal 2: An advisory “say-on-pay” vote on the compensation of the Company’s named executive officers was approved. Votes For Votes Against Votes Abstaining Broker Non-Votes 66,322,467 1,840,247 303,469 1,762,886”

CASELLA WASTE SYSTEMS INC shareholders approved Election of four Class II directors at the 2026-06-04 meeting.

“Proposal 1: The following nominees were elected to the Board as Class II directors, each to serve for a term expiring at the 2029 Annual Meeting of Stockholders. Nominee Votes For Votes Withheld Broker Non-Votes Michael L. Battles 50,246,273 18,219,910 1,762,886 Edmond R. Coletta 67,304,218 1,161,965 1,762,886 Joseph G. Doody (Class A Director) 52,671,841 5,912,342 1,762,886 Emily Nagle Green 45,499,951 22,966,232 1,762,886”

NeuroPace Inc shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-05 meeting.

“Proposal 2 - Ratification of Independent Registered Public Accounting Firm . NeuroPace’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as NeuroPace’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

NeuroPace Inc shareholders approved Election of Class II directors at the 2026-06-05 meeting.

“Proposal 1 - Election of Directors . NeuroPace’s stockholders elected each of the following Class II director nominees to hold office until NeuroPace’s 2029 Annual Meeting of Stockholders and until their successor is duly elected and qualified or until their earlier death, resignation or removal.”

Palladyne AI Corp. shareholders approved Approval of Restricted Stock Unit Awards to our Senior Executives.

“The restricted stock unit awards to our senior executives were approved. For Against Abstain Broker Non-Votes 19,630,273 3,440,470 169,787 9,575,723”

Palladyne AI Corp. shareholders approved Approval of the Company's 2021 Equity Incentive Plan, as amended and restated, to increase the number of shares authorized for issuance thereunder.

“The Company's 2021 Equity Incentive Plan, as amended and restated was approved. For Against Abstain Broker Non-Votes 16,236,339 6,865,822 138,369 9,575,723”

Palladyne AI Corp. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-12-31 meeting.

“The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 was ratified. For Against Abstain Broker Non-Votes 29,069,119 3,677,340 69,794 —”

Palladyne AI Corp. shareholders approved Election of Class II Director.

“The following nominee was elected as a Class II director to hold office until our 2029 annual meeting of stockholders and until his successor is elected and qualified or until his earlier death, resignation or removal. Nominee For Withhold Broker Non-Votes Dennis Weibling 19,383,890 3,856,640 9,575,723”

10x Genomics, Inc. shareholders approved Non-binding advisory vote to approve executive compensation of named executive officers at the 2026-06-04 meeting.

“Votes For Votes Against Abstentions Broker Non-Votes 176,677,540 2,828,730 748,296 18,560,952”

10x Genomics, Inc. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-04 meeting.

“Votes For Votes Against Abstentions Broker Non-Votes 197,719,939 458,231 637,346 —”

10x Genomics, Inc. shareholders approved Election of three Class I directors at the 2026-06-04 meeting.

“Nominee Votes For Votes Against Abstentions Broker Non-Votes Serge Saxonov 164,137,381 15,559,860 557,329 18,560,948 Benjamin J. Hindson 162,942,766 16,761,532 550,270 18,560,950 John R. Stuelpnagel 155,628,365 24,072,179 554,023 18,560,951”

Jaguar Health, Inc. shareholders approved Grant discretionary authority to adjourn the Annual Meeting, if necessary, to solicit additional proxies in the event that there are not sufficient votes at the time of the Annual Meeting to approve Proposals 3 and 4. at the 2026-06-08 meeting.

“Proposal to approve a proposal to grant discretionary authority to adjourn the Annual Meeting, if necessary, to solicit additional proxies in the event that there are not sufficient votes at the time of the Annual Meeting to approve Proposals 3 and 4, was approved by the stockholders by the following vote: For Against Abstained Broker Non- Votes 3,928,027 258,049 21,953 2,961,123”

Jaguar Health, Inc. shareholders approved Approve, pursuant to Nasdaq Listing Rule 5635(d), the issuance of more than 19.99% of the Company’s issued and outstanding shares of Common Stock to C/M Capital pursuant to a securities purchase agreement to be entered into within 90 days after the date of the Annual Meeting (the "Preferred Stock Pu at the 2026-06-08 meeting.

“Proposal to approve, pursuant to Rule 5635(d), the issuance of more than 19.99% of the Company’s issued and outstanding shares of Common Stock to C/M Capital pursuant to a securities purchase agreement to be entered between the Company and C/M Capital within 90 days after the date of the Annual Meeting (the “Preferred Stock Purchase Agreement”), including shares of Common Stock issuable upon redemption of shares of a new series of preferred stock of the Company, par value $0.0001 per share, to be designated as Series P Non-Convertible Preferred Stock (the “Series P Preferred Stock”), to be issued and sold pursuant to the Preferred Stock Purchase Agreement, was approved by the stockholders by the following vote: For Against Abstained Broker Non- Votes 3,846,847 336,712 24,470 2,961,123”

Jaguar Health, Inc. shareholders approved Approve, pursuant to Nasdaq Listing Rule 5635(d), the issuance of more than 19.99% of the Company’s issued and outstanding shares of Common Stock to C/M Capital Master Fund, LP (and its affiliates) pursuant to a securities purchase agreement to be entered into within 90 days after the date of the An at the 2026-06-08 meeting.

“Proposal to approve, pursuant to Nasdaq Listing Rule 5635(d) (Rule 5635(d)), the issuance of more than 19.99% of the Company’s issued and outstanding shares of Common Stock to C/M Capital Master Fund, LP (and its affiliates), an accredited investor (“C/M Capital”), pursuant to a securities purchase agreement to be entered into between the Company and C/M Capital within 90 days after the date of the Annual Meeting (the “ELOC Agreement”), was approved by the stockholders by the following vote: For Against Abstained Broker Non- Votes 3,891,273 291,441 25,315 2,961,123”

Jaguar Health, Inc. shareholders approved Ratify the appointment of RBSM LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-08 meeting.

“Proposal to ratify the appointment of RBSM LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved by the stockholders by the following vote: For Against Abstained Broker Non- Votes 6,898,326 238,443 32,383 0”

Jaguar Health, Inc. shareholders approved Election of one Class II director to the Company's board of directors to hold office for a three-year term until the annual meeting of stockholders in 2029 and until such director's successor is elected and qualified. at the 2026-06-08 meeting.

“Proposal to elect one Class II director to the Company’s board of directors to hold office for a three-year term until the annual meeting of stockholders in 2029 and until such director’s successor is elected and qualified. The votes regarding this proposal were as follows: For Withheld Broker Non- Votes John Micek III 3,967,085 240,944 2,961,123”